A survey of over 1,000 infection preventionists found that most healthcare facilities are implementing crisis standards of care when it comes to using personal protective equipment during the ongoing...
The controversy surrounding the notorious 340B Drug Pricing Program continues with more than 1,100 hospitals now urging HHS to stop pharmaceutical companies from refusing discounts for drugs covered by...
Providers and suppliers are looking to preserve the healthcare supply chain after the COVID-19 pandemic by prioritizing the purchase of products made in the US and other strategies, a recent survey...
Provider organizations are replacing or selecting new enterprise resource planning (ERP) systems to realize the benefits of a cloud solution, according to a recent KLAS Decisions Insights report.
In...
Hospitals across the country cannot keep up with coronavirus demands due to a severe COVID-19 testing shortage, and the lack of testing kits is exacerbating other key issues, including personal...
Group purchasing organizations (GPOs) are delivering critical cost-savings to providers, as well as increasing competition, transparency, and even emergency preparedness for events like COVID-19,...
Providers across the care continuum have been reporting significant personal protective equipment (PEE) shortages, but a new survey shows that primary care practices are being hit hard by supply chain...
Three-quarters of provider executives believe their corporate services spending could decrease without impacting quality of care or efficiency, according to a recent survey of over 100 hospital and...
As entire nations encourage their populations to stay inside to avoid COVID-19, healthcare providers are more active than ever in response to the outbreak of the novel coronavirus. This activity is...
UPDATE 03/06/2020: HR 6074 became public law no: 116-123 on March 6, 2020.
The federal government is one step closer to delivering funds to key stakeholders in the novel coronavirus...
A new list of essential medications is highlighting the fragility of the hospital supply chain. The list devised by group purchasing organization Vizient names 200 drugs that, if unavailable due to...
Hospital drug spending will increase by 3.59 percent through next year, indicating a “continuation of the sustained modest growth” observed over the last several years, according to the...
About $25.7 billion of hospital supply chain spending is considered unnecessary, a $2.7 billion increase from just two years ago, according to a Navigant analysis.
The analysis of 2,127...
More health systems are setting healthcare cost reduction goals, but their modest goals are leading to moderate success, according to a new survey conducted by Kaufman Hall and the Healthcare Financial...
As one of the largest non-profit health systems in the country, Banner Health relies on hundreds of contracts to ensure providers have the supplies they need to deliver high-quality care, and now spend...
A new survey from Johnson & Johnson Medical Devices Companies suggests health system clinicians and executives are moving beyond traditional cost cutting initiatives to address cost pressures and...
Physician practices and hospital outpatient clinics treat a similar number of commercially insured patients needing physician-administered drugs, but hospitals receive a larger share of the gross...
A physician’s top priority is always to deliver the highest quality care possible to patients. But in an increasingly sophisticated and difficult healthcare market, the providers are now finding...
Including inpatient and outpatient settings, hospital prescription drug spending is likely to increase by about 4.57 percent in 2020, according to Vizient’s July 2019 Drug Price Forecast.
The...
As the industry shifts from fee-for-service to value-based care, hospitals and health systems must focus on delivering the highest quality care at the lowest cost possible, and that extends to the...